CD19-directed Cytolytic Antibody drugs
1 medication in the FDA established pharmacologic class “CD19-directed Cytolytic Antibody”.
| Drug | Type | NDC products |
|---|---|---|
| Uplizna Inebilizumab | Rx | 1 |
1 medication in the FDA established pharmacologic class “CD19-directed Cytolytic Antibody”.
| Drug | Type | NDC products |
|---|---|---|
| Uplizna Inebilizumab | Rx | 1 |